Ophthalmology

New treatment target emerging for retinal damage

Scientists at the Medical College of Georgia at Augusta University are looking at new treatment targets for the retinal damage that often accompanies diseases like diabetes, glaucoma and hypertension.

Neuroscience

Faulty molecular master switch may contribute to AMD

A signaling pathway controlled by transforming growth factor beta (TGF-beta) could be involved in the progression of age-related macular degeneration (AMD). Researchers at the National Eye Institute (NEI), part of the National ...

Ophthalmology

Novel methods to treat glaucoma

Glaucoma is characterized by degeneration of retinal ganglion cells, leading to irreversible vision loss. Currently, the only treatable glaucoma risk factor is increased intraocular pressure. While lowering this pressure ...

Ophthalmology

Biomarkers facilitate early detection of glaucoma

Researchers at Ruhr-Universität Bochum have identified new potential biomarkers that may facilitate early detection of glaucoma in patients. Moreover, they ascertained that the mutation of a certain gene in mice causes intraocular ...

Neuroscience

Eyes have a natural version of night vision

To see under starlight and moonlight, the retina of the eye changes both the software and hardware of its light-sensing cells to create a kind of night vision. Retinal circuits that were thought to be unchanging and programmed ...

page 13 from 38